Pediapharm Files Corporate Presentation
12 sept. 2018 15h17 HE
|
Pediapharm Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. ...
Pediapharm Announces Transformative Acquisitions and $60 Million Offering of Subscription Receipts
06 sept. 2018 20h29 HE
|
Pediapharm Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. ...
13 pediatric kidney patients hope to become the cover artist for 2019 American Kidney Fund calendar
01 mai 2018 16h50 HE
|
American Kidney Fund
ROCKVILLE, Maryland, May 01, 2018 (GLOBE NEWSWIRE) -- Thirteen young kidney patients from across the country are lighting up their social networks asking friends and family to help put their artwork...
Cogstate Establishes Rare Disease and Pediatric Center of Excellence
05 avr. 2018 09h16 HE
|
Cogstate Ltd.
New Haven, CT, April 05, 2018 (GLOBE NEWSWIRE) -- The cognitive science company, Cogstate Ltd (ASX.CGS) today announced the establishment of a Rare Disease and Pediatric Center of Excellence to lead...
Cochlear Implant Systems Market worth over $2.5 billion by 2024: Global Market Insights, Inc.
22 févr. 2018 06h00 HE
|
Global Market Insights, Inc
Selbyville, Delaware, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Global Cochlear Implant Systems Market is projected to exceed USD 2.5 billion by 2024; according to a new research study published by Global...
Asklepion Pharmaceuticals Presents Phase 1b/2a Clinical Trial Data for IV-Citrulline at the Pediatric Cardiac Intensive Care Society 13th Annual International Meeting
08 déc. 2017 09h00 HE
|
Asklepion Pharmaceuticals, LLC.
BALTIMORE, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Asklepion Pharmaceuticals, LLC (“Asklepion” or “the Company”), a biotechnology company focused on the development of IV-citrulline for rare pediatric...
Global Vaccines Market to surpass $65 Bn by 2024: Global Market Insights, Inc.
20 nov. 2017 05h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Global Vaccines Market is poised to cross USD 65 billion by 2024; according to a new research report by Global Market Insights, Inc....
CURE Pharmaceutical Appoints CannaKids CEO and Cannabis Cancer Advocate Tracy Ryan to Advisory Board
27 juin 2017 09h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., June 27, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development...
Otonomy to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Corporate Update
24 févr. 2017 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Feb. 24, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Elsevier Announces First Large-Scale Analysis of Suicide Motivation Across Multiple Ages in the Same Time Period
13 févr. 2017 04h00 HE
|
Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - February 13, 2017) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of...